Firm expects its first product, human neural progenitor cells, will be ready in early 2007.
Aruna Biomedical will commercialize human neural progenitor cell technology developed at the University of Georgia Research Foundation.
Under the terms of the technology licensing agreement, Aruna acquired the exclusive worldwide right to develop and commercialize neural cells derived from human embryonic stem cells. Aruna will offer the academic and industry research communities access to much sought after but never before available human neural cells, derived from human embryonic stem cells that relate to normal and diseased human conditions .
Aruna anticipates launch of its first product, human neural progenitor (NP) cells, in early 2007 and add-on products will closely follow. The human NP cells will be sold and marketed through a third-party distribution partner and packaged as a kit with growth media and substrates.